TOVX CIK: 894158

Theriva Biologics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.9
FY22:
−19.1
FY23:
−19.0
FY24:
−16.9
FY25:
−16.7
Change from FY21 to FY25
millions USD
FY21:
−0.01
FY22:
−4.40
FY23:
−0.20
FY24:
0.00
FY25:
−0.04
Change from FY21 to FY25
millions USD
FY21:
74.0
FY22:
−1.93
FY23:
0.63
FY24:
5.50
FY25:
18.2
millions USD
FY21:
61.1
FY22:
−25.4
FY23:
−18.6
FY24:
−11.6
FY25:
1.40
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.9
FY22:
−19.2
FY23:
−19.2
FY24:
−16.9
FY25:
−16.7

All amounts in millions USD Data source:SEC EDGAR